Ascentage Pharma Group International - American Depository Shares (NQ:AAPG)

16.84 -0.58 (-3.30%)

Streaming Delayed Price Updated: 1:41 PM EDT, Aug 3, 2026 Add to My Watchlist

Price and Volume

Volume	7,499
Open	17.55
Bid (Size)	16.79 (3,800)
Ask (Size)	16.97 (300)
Prev. Close	17.42
Today's Range	16.80 - 17.55
52wk Range	16.36 - 48.45
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

July 26, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

June 14, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Performance

YTD	-36.1%	-36.1%
1 Month	-13.0%	-13.0%
3 Month	-23.5%	-23.5%
6 Month	-27.3%	-27.3%
1 Year	-55.2%	-55.2%

More News

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026

May 31, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026

May 31, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

May 31, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

May 21, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress

May 12, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma to Participate in Three Upcoming Investor Conferences

May 12, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026

April 21, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

March 25, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

March 17, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026

March 11, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma to Participate in Three Upcoming Investor Conferences

February 23, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288

January 06, 2026

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

November 10, 2025

Via Benzinga

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday ↗

November 05, 2025

Via Benzinga

Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗

August 25, 2025

Via Benzinga

Earnings Scheduled For August 20, 2025 ↗

August 20, 2025

Via Benzinga

US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns' ↗

July 08, 2025

Via Benzinga

Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday ↗

July 08, 2025

Via Benzinga

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance

July 07, 2025

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors

June 02, 2025

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report

June 02, 2025

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 27, 2025

Via Benzinga

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025

May 22, 2025

From ASCENTAGE PHARMA GROUP INTERNATIONAL

Via GlobeNewswire

Frequently Asked Questions

Is Ascentage Pharma Group International - American Depository Shares publicly traded?

Yes, Ascentage Pharma Group International - American Depository Shares is publicly traded.

What exchange does Ascentage Pharma Group International - American Depository Shares trade on?

Ascentage Pharma Group International - American Depository Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Ascentage Pharma Group International - American Depository Shares?

The ticker symbol for Ascentage Pharma Group International - American Depository Shares is AAPG on the Nasdaq Stock Market

What is the current price of Ascentage Pharma Group International - American Depository Shares?

The current price of Ascentage Pharma Group International - American Depository Shares is 16.84

When was Ascentage Pharma Group International - American Depository Shares last traded?

The last trade of Ascentage Pharma Group International - American Depository Shares was at 08/03/26 01:41 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.